目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.
多数糖尿病患者起病后6～15年开始出现微量白蛋白尿，10～15年后进入显性蛋白尿期，出现大量蛋白尿。
Most diabetic patients began to have microalbuminuria after 6 to 15 years when they were diagnosed diabetes, 10 to 15 years later they went into a period of large volume proteinuria.
应用推荐